DT Investment Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95 Sell
7
-283
-98% -$3.38K ﹤0.01% 510
2026
Q1
$1.74K Sell
290
-1,749
-86% -$13.2K ﹤0.01% 494
2025
Q4
$14.6K Hold
2,039
– – ﹤0.01% 378
2025
Q3
$21.8K Hold
2,039
– – ﹤0.01% 316
2025
Q2
$19.7K Sell
2,039
-799
-28% -$8.24K ﹤0.01% 327
2025
Q1
$42.3K Hold
2,838
– – ﹤0.01% 240
2024
Q4
$42.3K Sell
2,838
-498
-15% -$8.12K ﹤0.01% 246
2024
Q3
$63.8K Buy
3,336
+149
+5% +$3.09K 0.01% 229
2024
Q2
$66K Sell
3,187
-14
-0.4% -$278 0.01% 218
2024
Q1
$60.2K Hold
3,201
– – 0.01% 212
2023
Q4
$53.7K Hold
3,201
– – 0.01% 218
2023
Q3
$55.6K Hold
3,201
– – 0.01% 197
2023
Q2
$69.6K Hold
3,201
– – 0.01% 193
2023
Q1
$78.4K Hold
3,201
– – 0.01% 185
2022
Q4
$89.4K Hold
3,201
– – 0.01% 168
2022
Q3
$75K Buy
+3,201
New +$96.6K 0.01% 171

Other funds holding OGN

DT Investment Partners's OGN Position: Q2 2026 in Review

DT Investment Partners reduced its Organon & Co (OGN) stake by 98% in Q2 2026, selling an estimated $3.38K and leaving 7 shares worth $95. The position accounts for ﹤0.01% of the portfolio, ranked #510.

DT Investment Partners first reported a position in OGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $89.4K in Q4 2022. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • DT Investment Partners held 7 shares of Organon & Co worth $95 as of Q2 2026.
  • DT Investment Partners sold 283 Organon & Co shares in Q2 2026, an estimated $3.38K.
  • Organon & Co made up ﹤0.01% of DT Investment Partners's portfolio in Q2 2026, its #510 holding.
  • DT Investment Partners first reported a position in Organon & Co in Q3 2022 and has held it in 16 quarters since.
  • DT Investment Partners's Organon & Co position peaked at $89.4K in Q4 2022.
  • 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.